Brussels, 1 April 2009 - Today, 1,344,168 ordinary shares of Auriga International were admitted on to the Free Market of NYSE Euronext Brussels.
A total of 94,168 new shares were subscribed, raising €542,000. At the IPO price of €5.76 per share, the market capitalization of the company amounts to €7.8 million. Auriga International is a cosmetics/pharmaceutical company which uses advanced technology to develop and create original treatments in the fields of dermatology, plastic surgery and cosmetic medicine.